期刊
CLINICAL SCIENCE
卷 125, 期 5-6, 页码 291-300出版社
PORTLAND PRESS LTD
DOI: 10.1042/CS20120612
关键词
aortic valve stenosis; myocardial remodelling; NADPH oxidase; Nox4; pressure overload
资金
- Foundation for Applied Medical Research
- 'UTE project CIMA'
- Ministry of Economy and Competitiveness [RE-CAVA RD06/0014/0008, SAF-2010-20367, RYC-2010-05797]
- European Union [MEDIA project] [HEALTH-F2-2010-261409]
- British Heart Foundation
- Foundation Leducq Transatlantic Network of Excellence award
- British Heart Foundation [RG/08/011/25922] Funding Source: researchfish
The NADPH oxidases are a key family of ROS (reactive oxygen species)-producing enzymes which may differentially contribute to cardiac pathophysiology. Animal studies show uncertain results regarding the regulation of cardiac Nox4 by pressure overload and no data are available on human myocardial Nox4. In the present study, we evaluated Nox4 expression and its relationship with myocardial remodelling and LV (left ventricular) function in patients with severe AS (aortic valve stenosis). Endomyocardial biopsies from 34 patients with AS were obtained during aortic valve replacement surgery. LV morphology and function were assessed by echocardiography. Myocardial samples from subjects deceased of non-CVDs (cardiovascular diseases) were analysed as controls. Nox4 localization was evaluated by immunohistochemistry and quantified by Western blot. Myocardial capillary density, fibrosis and cardiomyocyte dimensions and apoptosis were assessed histologically to evaluate myocardial remodelling. Nox4 was present in samples from all subjects and expressed in cardiomyocytes, VSMCs (vascular smooth muscle cells), endothelium and fibroblasts. Nox4 levels were reduced 5-fold in AS patients compared with controls (P < 0.01). Nox4 levels directly correlated with cardiomyocyte cross-sectional area (r = 0.299, P < 0.05) and diameter (r = 0.406, P < 0.05) and capillary density (r = 0.389, P < 0.05), and inversely with cardiomyocyte apoptosis (r = -0.316, P < 0.05) in AS patients. In addition, Nox4 levels correlated with echocardiographic parameters (LV ejection fraction: r = 0.353, P < 0.05; midwall fractional shortening: r = 0.355, P < 0.05; deceleration time: r = -0.345, P < 0.05) in AS patients. Nox4 is expressed in human myocardium and reduced in AS patients. The observed associations of Nox4 with cardiomyocyte parameters and capillary density in AS patients suggest a potential role of Nox4 deficiency in the myocardial remodelling present in the human pressure-overloaded heart.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据